TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
HCC, Hepatocellular Carcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ChemoSen↑, TumCP↓, cycD1/CCND1↓, MMP9↓,
TumCP↓, ROS↑, NRF2↑, BAX↑, P53↑, Cyt‑c↑, Casp9↑, Casp3↑, Bcl-2↓,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
NF-kB↓, angioG↓, Inflam↓, TumCP↓, TumCMig↓, TumCI↓, Sp1/3/4↓, VEGF↓, angioG↓, uPA↓, PDGF↓, MCP1↓, ICAM-1↓, *NRF2↑, *hepatoP↑,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
HL7702 |
|
|
|
Keap1↑, NRF2↓, EMT↓, TumCP↓, TumCI↓, selectivity↑, *toxicity↓, ROS↑, MDA↑, GSH↓, Ferroptosis↑,
ChemoSen↑, TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, MMPs↓, MAPK↓, TGF-β↓, ZFX↓, p‑MEK↓, ERK↓, MMP2↓, MMP9↓, uPA↓, TIMP1↓, TIMP2↓, NF-kB↓, p65↓, p‑IKKα↓, Fas↑, Casp2↑, Casp3↑, Casp8↑, Casp9↑, Bcl-xL↓, BAX↑, ER Stress↑, Ca+2↑, JNK↑, P53↑, ROS↑, H2O2↑, cMyc↓, CD24↓, 12LOX↓,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
BC, |
MGC803 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
GLUT1↓, TumCP↓,
| - |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, glut↓, SLC12A5↓, cMyc↓, GLS↓,
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Glycolysis↓, Hif1a↓, GLUT1↓, HK2↓, PKM2↓, LDHA↓,
| - |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
in-vitro, |
HCC, |
H1299 |
|
|
|
TumCP↓, ROS↑, antiOx↓, TumCG↓, TumCMig↓, NRF2↓, GPx4↓, HO-1↓, NCOA4↑, FTH1↓, Ferritin↑, Ferroptosis↑, GSH↓, MDA↓,
tumCV↓, Apoptosis↑, TumCP↓, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, lipid-P↓,
TumCP↓, TumCMig↓, TumCCA↑, MMP∅, MMP2↓, MMP9↓, α-SMA↓, COL1A1↓, COL3A1↓, TIMP1↓,
| - |
in-vitro, |
HCC, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
PFK↓, Glycolysis↓, lactateProd↓, GlucoseCon↓, TumCP↓, TumCCA↑, Casp3↑, cl‑PARP↑, Apoptosis↑, Casp8↑, Casp9↑, Cyt‑c↝, MMP↓, BAD↑, GLUT2↓, PKM2∅,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
STAT3↓, Akt↓, cSrc↓, JAK1↓, JAK2↓, SHP1↑, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, Mcl-1↓, survivin↓, VEGF↓, TumCP↓, Casp3↑, cl‑PARP↑, ChemoSen↑, XIAP↓,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
vitro+vivo, |
Liver, |
HUH7 |
|
|
|
STAT3↓, TumCP↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, Mcl-1↓, survivin↓, VEGF↓, TumCCA↑, TumVol↓,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
NA, |
NA, |
Hep3B |
|
|
|
- |
NA, |
NA, |
SK-HEP-1 |
|
|
|
TumCP↓, TumCCA↑, Apoptosis↑, Akt↓, NF-kB↓, TumCG↓, angioG↓,
TumCP↓, Apoptosis↓, PKM2↓, TumAuto↑,
TumCP↓, cycD1/CCND1↓, MMP9↓, TumCMig↓,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
TumCP↓, TumCCA↓, Apoptosis↑, GlucoseCon↓, lactateProd↓, PKM2↓, Glycolysis↓, HK2↓, PFK↓, OXPHOS↑, ChemoSen↑, HSP90↓, Hif1a↓,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
Glycolysis↓, Apoptosis↑, TumCP↓, lactateProd↓, GlucoseCon↓, HK2↓, ChemoSen↑, *toxicity↓, cMyc↓, PFK1↓, LDHA↓, cMyc↓, ChemoSen↑,
TumCP↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, GLUT1↓, GLUT2↓, LDHA↓, HK2↓, PKM2↓, PFK↓, Dose↝,
TumCP↓, Apoptosis↑, ROS↑, TumAuto↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, BAD↑, Bcl-2↓, toxicity↓, hepatoP↑, GSH↓,
| - |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, HK2↓, Akt↓, mTOR↓, GlucoseCon↓, lactateProd↓, Glycolysis↓,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
HK2↓, ChemoSen↑, other↑, Glycolysis↓, lactateProd↓, TumCP↓, Casp3↑, cl‑PARP↑, PKM2↓,
| - |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
TumCP↓, TumCCA↑, Apoptosis↑, EMT↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, TumCMig↓, MMPs↓, Vim↓,
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, MMP↓, ROS↑, OCR↓, ATP↓, PKM2↓,
HSD17B4↓, Akt↓, MEK↓, ERK↓, STAT3↓, TumCP↓,
Showing Research Papers: 1 to 26 of 26
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 26
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, Ferroptosis↑, 2, GPx4↓, 1, GSH↓, 3, H2O2↑, 1, HO-1↓, 1, Keap1↑, 1, lipid-P↓, 1, MDA↓, 1, MDA↑, 1, NRF2↓, 2, NRF2↑, 1, OXPHOS↑, 1, ROS↑, 6,
Metal & Cofactor Biology ⓘ
Ferritin↑, 1, FTH1↓, 1, NCOA4↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MEK↓, 1, p‑MEK↓, 1, MMP↓, 2, MMP∅, 1, OCR↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, cMyc↓, 4, GLS↓, 1, GlucoseCon↓, 5, glut↓, 1, GLUT2↓, 2, Glycolysis↓, 7, HK2↓, 6, HSD17B4↓, 1, lactateProd↓, 6, LDHA↓, 3, PFK↓, 3, PFK1↓, 1, PKM2↓, 6, PKM2∅, 1,
Cell Death ⓘ
Akt↓, 5, Apoptosis↓, 1, Apoptosis↑, 9, BAD↑, 2, BAX↑, 3, Bcl-2↓, 4, Bcl-xL↓, 3, Casp2↑, 1, Casp3↑, 5, cl‑Casp3↑, 1, Casp8↑, 2, Casp9↑, 3, Cyt‑c↑, 1, Cyt‑c↝, 1, Fas↑, 1, Ferroptosis↑, 2, JNK↑, 1, MAPK↓, 1, Mcl-1↓, 2, survivin↓, 2,
Kinase & Signal Transduction ⓘ
cSrc↓, 1, Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
other↑, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 2,
DNA Damage & Repair ⓘ
P53↑, 2, cl‑PARP↑, 4,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 4, TumCCA↓, 1, TumCCA↑, 6,
Proliferation, Differentiation & Cell State ⓘ
CD24↓, 1, EMT↓, 2, ERK↓, 2, mTOR↓, 2, PI3K↓, 1, SHP1↑, 1, STAT3↓, 3, TumCG↓, 2, ZFX↓, 1,
Migration ⓘ
Ca+2↑, 1, COL1A1↓, 1, COL3A1↓, 1, MMP2↓, 3, MMP9↓, 5, MMPs↓, 2, PDGF↓, 1, TGF-β↓, 1, TIMP1↓, 2, TIMP2↓, 1, TumCI↓, 7, TumCMig↓, 9, TumCP↓, 26, uPA↓, 2, Vim↓, 1, α-SMA↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 3, Hif1a↓, 2, VEGF↓, 3,
Barriers & Transport ⓘ
GLUT1↓, 3, SLC12A5↓, 1,
Immune & Inflammatory Signaling ⓘ
ICAM-1↓, 1, p‑IKKα↓, 1, Inflam↓, 1, JAK1↓, 1, JAK2↓, 1, MCP1↓, 1, NF-kB↓, 3, p65↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 7, Dose↝, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
Ferritin↑, 1,
Functional Outcomes ⓘ
hepatoP↑, 1, toxicity↓, 1, TumVol↓, 1,
Total Targets: 116
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
NRF2↑, 1,
Functional Outcomes ⓘ
hepatoP↑, 1, toxicity↓, 2,
Total Targets: 3
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:10 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page